Archive for septembre, 2023

OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer

OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer

The Call-off for Phase 2 was launched in early July 2023 where four successful suppliers from Phase 1 were invited to submit an offer.  […]
Read More